Indian Pharmacopoeia Commission Hosts National Conference on Biosimilar Quality and Safety to Strengthen India's Biopharma SHAKTI Vision
Distilled Policy Brief
- The Indian Pharmacopoeia Commission (IPC), an autonomous institution under the Ministry of Health and Family Welfare, organized a two-day national conference in Bengaluru to strengthen India's 'Biopharma SHAKTI' vision, focusing on the quality, safety, and regulatory pathways of biosimilars.
- A major milestone of the conference was the launch of the Indian Pharmacopoeia Reference Standard (IPRS) for Enoxaparin Sodium (a low molecular weight heparin anticoagulant) for bioassays, establishing a certified reference material to ensure precise and uniform biological activity evaluation.
- The initiative aims to bolster India's indigenous drug quality infrastructure, reduce import dependency for reference standards, and foster collaboration among regulators, industry (via BIRAC and C-CAMP), and academia to achieve global competitiveness.
🎯 Prelims High-Yield Examination Points
Indian Pharmacopoeia Reference Standard (IPRS) for Enoxaparin Sodium and the Biopharma SHAKTI Vision.
⚖️ Mains Analytical & Syllabus Linkages
Analyzing the regulatory, infrastructural, and standardization challenges in India's biosimilar ecosystem and the role of indigenous standards in achieving global pharmaceutical leadership.
🎯 UPSC Prelims Practice Drill
With reference to the Indian Pharmacopoeia Reference Standard (IPRS) and recent developments in India's biopharmaceutical sector, consider the following statements: 1. The Indian Pharmacopoeia Commission (IPC) is an autonomous institution under the Ministry of Science and Technology. 2. Enoxaparin Sodium, for which an IPRS was recently launched, is a low molecular weight heparin anticoagulant used to prevent and treat thromboembolic disorders. 3. The indigenous development of IPRS for bioassays aims to establish certified reference materials to reduce import dependency. Which of the statements given above are correct?
- [A] 1 and 2 only
- [B] 2 and 3 only
- [C] 1 and 3 only
- [D] 1, 2 and 3
▶ Reveal Official Answer & Analytical Explanation
Statement 1 is incorrect because the Indian Pharmacopoeia Commission (IPC) is an autonomous institution under the Ministry of Health and Family Welfare, not the Ministry of Science and Technology. Statements 2 and 3 are correct as Enoxaparin Sodium is a low molecular weight heparin anticoagulant, and the newly launched IPRS serves as a certified reference material to ensure precise biological activity evaluation and reduce import dependency.
🏛️ Historical Twin PYQ Anchor (2021)
Consider the following statements regarding the "National Clean Air Programme (NCAP)": 1. It is implemented by the Ministry of Environment, Forest and Climate Change. 2. Central Pollution Control Board acts as the sole regulatory executive body.